Menu
ncarol.com
  • Home
  • Books
  • Music
  • Manufacturing
  • Book Release
  • Asheville Music
  • Real Estate
  • Health
  • Business
ncarol.com

Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
ncarol.com/10258250

Trending...
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 109
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million - 101
  • Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
DURHAM, N.C., April 16, 2024 ~ Prime Healthcare and EmVenio Research have joined forces to launch the EmVenio Research Center at Prime Healthcare, a new initiative that aims to improve access to clinical research for patients while also expanding the research capabilities of Prime Healthcare hospitals.

EmVenio Research, a community research provider, will now have the opportunity to conduct research at Prime Healthcare hospitals and offer patients improved access to clinical trials. This partnership is expected to increase participation in clinical trials by creating awareness of research within communities and providing local access to global research opportunities.

With 44 hospitals and over 300 outpatient locations across the United States, Prime Healthcare is one of the nation's leading health systems. Known for its commitment to quality excellence and innovation, Prime Healthcare will provide the necessary infrastructure and clinical support for EmVenio Research to conduct advanced clinical trials.

Through this collaboration, EmVenio will work with Prime Healthcare hospitals to identify potential candidates for clinical trials using Health Wizz. This secure platform connects with Electronic Health Records (EHR) systems, protecting patient data while streamlining the process of identifying, screening, and enrolling study participants. All data collected will be kept secure and used only with patient consent.

More on ncarol.com
  • Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
  • TekTone innovation meets patient care
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams

Thad Wolfram, President of EmVenio Research, expressed his excitement about this partnership stating that their priority is delivering value to communities while successfully enrolling and retaining patients for their customers. He believes that through this collaboration with Prime Healthcare and Health Wizz, EmVenio will expand its community-based research footprint and be able to recruit an ever-growing patient base for clinical trials.

Dr. Sunny Bhatia, President and Chief Medical Officer of Prime Healthcare, also shared his enthusiasm about this partnership. He believes that EmVenio's expertise in designing and implementing clinical studies will keep the EmVenio Research Center at Prime Healthcare at the forefront of medical research and discovery. Dr. Bhatia hopes that by offering these opportunities to patients at Prime hospitals, they will have better clinical experiences and outcomes.

Nitin Desai, MD, President and Chief Medical Officer of Health Wizz, also expressed his pride in being a part of this visionary collaboration. He believes that by integrating their technology solutions, they can enhance the efficiency and security of enrolling study participants in clinical trials, ultimately benefiting both patients and researchers.

More on ncarol.com
  • P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
  • DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
  • Crawler Record for WordPress Version 1.0
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection

The EmVenio Research Center at Prime Healthcare will make clinical research available to patients at Prime hospitals across the country, starting with California, Alabama, Texas, and Georgia. This will provide clinical trial sponsors and Contract Research Organizations (CROs) with access to a large and diverse patient population that was previously unavailable to them. With the detailed data available through this partnership, it is expected that there will be improved study feasibility, leading to reduced screen failure rates and increased enrollment certainty.

This service offering includes a hybrid approach that seamlessly integrates brick-and-mortar sites, mobile sites, and in-home research. This unique collaboration between EmVenio Research, Prime Healthcare, and Health Wizz marks a significant milestone in EmVenio's evolution and service repertoire.

Wolfram believes that the EmVenio Research Center at Prime Healthcare will set them apart for patients, communities, partners, and clients alike. This partnership is expected to bring about positive changes in the world of clinical research by providing better opportunities for patients while also expanding research capabilities for healthcare providers.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
  • MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
  • From Detroit Streets to Blue Ridge Mountains: KayeDinero Finds a New Sound in Western North Carolina
  • Why Did KayeDinero Name a Song After Hendersonville?
  • Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
  • Did Asheville's BoomTown Weekend Inspire KayeDinero's Next Move?
  • From City Girl to Mountain Life: KayeDinero Releases "City Girl Saved" From Asheville
  • Lake Norman Philharmonic - Free Community Concert
  • Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
  • Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
  • Ubora Thrive AI Welcomes Ubuntu Holistic Counseling as Strategic Business Ambassador
  • ChargeOn Announces Conversational Payment Management Solution
  • King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
  • New from Regal House, Uprooted, building a farm in a memoir of trauma, resilience, and becoming
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 148
  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 145
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 135
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate - 129
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 128
  • KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night - 122
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History - 116
  • BumbleBeeSmart Launches Dedicated Sensory Wall Panels Collection for Adults, Memory Care and Senior Living - 114
  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners - 114
  • Bspin Launches Lightning-Fast Crypto Gaming Expansion With Sportsbook, Poker, VIP Rewards, and Bitcoin Lightning Network Integration - 114

Similar on ncarol.com

  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • ChargeOn Announces Conversational Payment Management Solution
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute